LewisAChodoshMD
Endocrinology • Philadelphia, PADiabetes, Lipid Metabolism
Chairman, Dept of Cancer Biology
Dr. Chodosh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
612 BRB 2/3, 421 Curie Blvd.
University of Pennsylvania
Philadelphia, PA 19104Phone+1 215-898-1321- Is this information wrong?
Education & Training
Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1994- Massachusetts General HospitalResidency, Internal Medicine, 1989 - 1991
Harvard Medical SchoolClass of 1989
Certifications & Licensure
PA State Medical License 1994 - 2024
MA State Medical License 1991 - 2024
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2002
Publications & Presentations
PubMed
- Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.Lawrence-Paul, M., Pan, T., Pant, D., Shih, N., Chen, Y., Belka, G., Feldman, M., DeMichele, A., Chodosh, L.> ;Genome Medicine. 2024 Feb 6
- 1 citationsTargeting cancer cell dormancy.Agudo, J., Aguirre-Ghiso, J., Bhatia, M., Correia, A., Klein, C., Chodosh, L.> ;Nature Reviews. Cancer. 2024 Feb 1
- 1 citationsB3GALT6 promotes dormant breast cancer cell survival and recurrence by enabling heparan sulfate-mediated FGF signaling.Sreekumar, A., Lu, M., Choudhury, B., Pan, T., Pant, D., Lawrence-Paul, M., Sterner, C., Belka, G., Toriumi, T., Benz, B., Escobar-Aguirre, M., Marino, F., Esko, J., C...> ;Cancer Cell. 2024 Jan 8
- Join now to see all
Press Mentions
Dormant Cancer Cells May 'Reawaken' Due to Change in This Key ProteinDecember 14th, 2021- Applied Cells Inc. Enters Collaborative Research Agreement for Rare Cell Isolation in Minimum Residual DiseaseApril 26th, 2021
- G9a Promotes Breast Cancer Recurrence Through Repression of a Pro-Inflammatory ProgramNovember 3rd, 2020
- Join now to see all
Grant Support
- Role Of SNF1 Kinase Hunk In Breast Cancer ProgressionNational Cancer Institute2010–2012
- Minimal Residual Disease And Mechanisms Of Breast Cancer RecurrenceNational Cancer Institute2010–2012
- In Vivo Oncogene-Induced Tumorigenesis And EscapeNational Cancer Institute2010–2012
- The Impact Of Exercise And Caloric Restriction On Cancer Recurrence In MiceNational Cancer Institute2011
- Novel PET Imaging Agents For Understanding Glutamine Addiction In CancerNational Cancer Institute2011
- Developmental Research CoreNational Cancer Institute2011
- Survival And Recurrence Of Dormant Cancer CellsNational Cancer Institute2010–2011
- Mechanisms Of Breast Cancer ProgressionNational Cancer Institute2009–2011
- PENN Small Animal Imaging Resource (Penn-Sair)National Cancer Institute2007–2011
- Analysis Of Tumor Dynamics In Progression And MetastasisNational Cancer Institute2004–2009
- In Vivo Ras-Induced Senescence And TumorigenesisNational Cancer Institute2003–2007
- Mechanisms Of Progression In C-Myc-Induced Breast CancerNational Cancer Institute2002–2006
- Temporal Analysis Of Mammary CarcinogenesisNational Cancer Institute2003–2005
- Mammary Development And Breast Cancer SusceptibilityNational Cancer Institute2001–2005
- Hunk And Punc Function In Mammary Epithelial BiologyNational Cancer Institute2000–2004
- Temporal Analysis Of Mammary CarcinogenesisNational Cancer Institute2002
- Modulation Of Breast Cancer Susceptibility By Reproductive HistoryNational Cancer Institute1998–2002
- BRCA2 Function In Mammary Epithelial BiologyNational Cancer Institute1998–2002
- BRCA1 And Differentiation And Endocrine Risk FactorNational Cancer Institute1996–2000
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
